Amylyx's Co-CEOs comment on Friday's European CHMP decision on their ALS therapy
Josh Cohen and Justin Klee give their thoughts on the negative opinion, what it means for ALS patients in Europe, and a new statistical analysis of the CENTAUR study.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square